Skip to main navigation Skip to search Skip to main content

Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis

59 Citations (Scopus)

Abstract

Patients with rheumatoid arthritis (RA) have excess morbidity and mortality due to ischemic heart disease. It has been suggested that high serum levels of mannose-binding lectin (MBL) and agalactosyl IgG (IgG-G0) are associated with increased inflammation in RA. MBL also enhances inflammation-mediated tissue injury during postischemic reperfusion. This study was undertaken to examine whether these factors are associated with increased risk of ischemic heart disease in RA.
Original languageEnglish
JournalArthritis & Rheumatism
Volume56
Issue number1
Pages (from-to)21-9
Number of pages9
ISSN0004-3591
DOIs
Publication statusPublished - Jan 2007

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Arthritis, Rheumatoid
  • Comorbidity
  • Denmark
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Immunoglobulin G
  • Male
  • Mannose-Binding Lectin
  • Middle Aged
  • Myocardial Ischemia
  • Polymorphism, Genetic
  • Proportional Hazards Models
  • Prospective Studies
  • Survival Rate

Fingerprint

Dive into the research topics of 'Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this